Single-cell analysis of targeted transcriptome predicts drug sensitivity of single cells within human myeloma tumors
出版年份 2015 全文链接
标题
Single-cell analysis of targeted transcriptome predicts drug sensitivity of single cells within human myeloma tumors
作者
关键词
-
出版物
LEUKEMIA
Volume 30, Issue 5, Pages 1094-1102
出版商
Springer Nature
发表日期
2015-12-29
DOI
10.1038/leu.2015.361
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Critical Role for the DNA Sensor AIM2 in Stem Cell Proliferation and Cancer
- (2015) Si Ming Man et al. CELL
- Causes and consequences of crossing-over evidenced via a high-resolution recombinational landscape of the honey bee
- (2015) Haoxuan Liu et al. GENOME BIOLOGY
- mice: Multivariate Imputation by Chained Equations inR
- (2015) Stef van Buuren et al. Journal of Statistical Software
- Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
- (2014) Jens G. Lohr et al. CANCER CELL
- High-throughput drug screening identifies compounds and molecular strategies for targeting proteasome inhibitor-resistant multiple myeloma
- (2014) H A F Stessman et al. LEUKEMIA
- Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma
- (2014) L Melchor et al. LEUKEMIA
- Single-cell gene expression signatures reveal melanoma cell heterogeneity
- (2014) M Ennen et al. ONCOGENE
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
- (2014) A. P. Patel et al. SCIENCE
- Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
- (2014) Niccolo Bolli et al. Nature Communications
- Multiple myeloma: 2013 update on diagnosis, risk-stratification, and management
- (2013) S. Vincent Rajkumar AMERICAN JOURNAL OF HEMATOLOGY
- Carfilzomib
- (2013) K. M. Kortuem et al. BLOOD
- High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma
- (2013) Edmund A. Mroz et al. CANCER
- New Strategies in the Treatment of Multiple Myeloma
- (2013) N. C. Munshi et al. CLINICAL CANCER RESEARCH
- Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms
- (2013) B A Walker et al. LEUKEMIA
- New orally active proteasome inhibitors in multiple myeloma
- (2013) Alessandro Allegra et al. LEUKEMIA RESEARCH
- Profiling Bortezomib Resistance Identifies Secondary Therapies in a Mouse Myeloma Model
- (2013) H. A. F. Stessman et al. MOLECULAR CANCER THERAPEUTICS
- Bortezomib Resistance Can Be Reversed by Induced Expression of Plasma Cell Maturation Markers in a Mouse In Vitro Model of Multiple Myeloma
- (2013) Holly A. F. Stessman et al. PLoS One
- Proteasome inhibitors in multiple myeloma: 10 years later
- (2012) P. Moreau et al. BLOOD
- Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides
- (2012) J. B. Egan et al. BLOOD
- Clonal competition with alternating dominance in multiple myeloma
- (2012) J. J. Keats et al. BLOOD
- Proteasome Inhibitors: An Expanding Army Attacking a Unique Target
- (2012) Alexei F. Kisselev et al. CHEMISTRY & BIOLOGY
- Molecular pathogenesis of multiple myeloma and its premalignant precursor
- (2012) W. Michael Kuehl et al. JOURNAL OF CLINICAL INVESTIGATION
- A gene expression signature for high-risk multiple myeloma
- (2012) R Kuiper et al. LEUKEMIA
- Minor clone provides a reservoir for relapse in multiple myeloma
- (2012) F Magrangeas et al. LEUKEMIA
- Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials
- (2011) B. C. Potts et al. CURRENT CANCER DRUG TARGETS
- Genetic variations in multiple myeloma II: association with effect of treatment
- (2011) Annette Vangsted et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Future Directions of Next-Generation Novel Therapies, Combination Approaches, and the Development of Personalized Medicine in Myeloma
- (2011) Constantine S. Mitsiades et al. JOURNAL OF CLINICAL ONCOLOGY
- Regression shrinkage and selection via the lasso: a retrospective
- (2011) Robert Tibshirani JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY
- Initial genome sequencing and analysis of multiple myeloma
- (2011) Michael A. Chapman et al. NATURE
- Multiple Myeloma
- (2011) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines
- (2010) J. Moreaux et al. HAEMATOLOGICA
- Inferring tumor progression from genomic heterogeneity
- (2009) N. Navin et al. GENOME RESEARCH
- International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
- (2009) R Fonseca et al. LEUKEMIA
- High-risk myeloma: a gene expression based risk-stratification model for newly diagnosed multiple myeloma treated with high-dose therapy is predictive of outcome in relapsed disease treated with single-agent bortezomib or high-dose dexamethasone
- (2008) F. Zhan et al. BLOOD
- Many facets of bortezomib resistance/susceptibility
- (2008) S. Kumar et al. BLOOD
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started